Session 3 – Accelerating Biomedical Innovations
Date: 22 July (Wednesday) 12:20 – 13:50 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform
Jian-Bing Fan, Founder and CEO, AnchorDx Corp, a company that is currently working on a broad range of clinical products toward the realization of early cancer detection and diagnosis. The company has raised $38 millions since its inception; has developed proprietary technologies and several advanced clinical programs in lung, colorectal, breast and bladder cancers. Dr. Fan has over 20 years of experience in human genome research and microarray/next-gen sequencing technology development. He has developed a series of genomics technology and products at Illumina and Affymetrix for high throughput genotyping, gene expression and methylation analysis. Dr. Fan received his PhD in Genetics from Columbia University. He has authored 179 original articles and book chapters, published one book, been granted 23 US/world patents, and served/serving on the editorial board of scientific journals Genome Research and Translational Cancer Research, and is currently an executive editor of Genomics.